2019
DOI: 10.37621/jnamsu-2019-4-457-462
|View full text |Cite
|
Sign up to set email alerts
|

Efficiency of antituberculosis measures in the improvement of tuberculosis control in Ukraine

Abstract: The study was aimed to estimate positive aspects and lacks of tuberculosis (TB) control in Ukraine on the basis of analysis of reports of antituberculosis dispensaries in 2012–2017 years. Positive changes in an epidemic situation on ТB in 2012–2017 were marked by an increase of the detectability percent of patients with ТB by sputum smear and culture, an increase of percent of clinical recovery of patients, reduction in ТB sick rate among medical workers, and, as a result, reduction of the incidence of all for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 6 publications
0
1
0
1
Order By: Relevance
“…Based on data derived from medical records, patients were placed into three groups according to the Pneumonia Patient Outcomes Research Team (PORT) score: patients with pneumonia of a Risk Class II (n = 124, group II), Risk Class III (n = 68, group III), and Risk Class IV (n = 16, group IV) according to the Ukrainian adapted evidence-based clinical guideline "Nosocomial pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antimicrobial therapy and prevention" (Feshchenko et al, 2019) based on NICE Guideline 191: Pneumonia: Diagnosis and management of community-and hospital acquired pneumonia in adults (NICE, 2022).…”
Section: Study Design and Research Samplementioning
confidence: 99%
“…Based on data derived from medical records, patients were placed into three groups according to the Pneumonia Patient Outcomes Research Team (PORT) score: patients with pneumonia of a Risk Class II (n = 124, group II), Risk Class III (n = 68, group III), and Risk Class IV (n = 16, group IV) according to the Ukrainian adapted evidence-based clinical guideline "Nosocomial pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antimicrobial therapy and prevention" (Feshchenko et al, 2019) based on NICE Guideline 191: Pneumonia: Diagnosis and management of community-and hospital acquired pneumonia in adults (NICE, 2022).…”
Section: Study Design and Research Samplementioning
confidence: 99%
“…Туберкульоз є глобальною проблемою системи охорони здоров'я як одна з 10 провідних причин смерті у світі [1][2][3]. В Україні щодня реєструють майже 100 нових випадків захворювання на туберкульоз.…”
Section: вступunclassified